R Michael Carruthers Edgewise Therapeutics, Inc. (EWTX) insider trading activity

R Michael Carruthers is Chief Financial Officer of Edgewise Therapeutics, Inc.. Currently has a direct ownership of 86,162 shares of EWTX, which is worth approximately $1.15 Million. The most recent transaction as insider was on Aug 12, 2025, when has been sold 1,428 shares (Common Stock) at a price of $13.39 per share, resulting in proceeds of $19,120. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86.2K

6.35% 3M change

144.57% 12M change

Total Value Held $1.15 Million

R Michael Carruthers Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 12 2025	SELL Open market or private sale	$19,120 $13.39 p/Share	1,428 Reduced 1.63%	86,162 Common Stock
Aug 12 2025	BUY Exercise of conversion of derivative security	-	5,781 Added 6.19%	87,590 Common Stock
May 02 2025	SELL Open market or private sale	$21,615 $16.45 p/Share	1,314 Reduced 1.6%	81,014 Common Stock
May 01 2025	BUY Exercise of conversion of derivative security	-	5,209 Added 5.95%	82,328 Common Stock
Oct 11 2024	BUY Exercise of conversion of derivative security	$49,700 $0.71 p/Share	70,000 Added 47.65%	76,904 Common Stock
Sep 20 2024	SELL Open market or private sale	$3,575,129 $28.58 p/Share	125,092 Reduced 94.77%	6,904 Common Stock
Sep 20 2024	BUY Exercise of conversion of derivative security	$185,411 $1.93 p/Share	96,068 Added 62.8%	56,904 Common Stock
May 02 2024	SELL Open market or private sale	$40,788 $18.91 p/Share	2,157 Reduced 5.77%	35,230 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	-	5,208 Added 12.23%	37,387 Common Stock
Jan 23 2024	SELL Open market or private sale	$1,420,200 $15.78 p/Share	90,000 Reduced 75.62%	29,024 Common Stock
Jan 23 2024	BUY Exercise of conversion of derivative security	$173,700 $1.93 p/Share	90,000 Added 43.06%	119,024 Common Stock
Jun 22 2023	BUY Exercise of conversion of derivative security	$7,100 $0.71 p/Share	10,000 Added 25.63%	29,024 Common Stock
May 02 2023	SELL Open market or private sale	$11,890 $8.9 p/Share	1,336 Reduced 7.65%	16,126 Common Stock
May 01 2023	BUY Exercise of conversion of derivative security	-	5,208 Added 22.97%	17,462 Common Stock
May 23 2022	BUY Exercise of conversion of derivative security	$6,390 $0.71 p/Share	9,000 Added 42.86%	12,000 Common Stock

Also insider at

RPHM

Reneo Pharmaceuticals, Inc. Healthcare

ELEV

Elevation Oncology, Inc. Healthcare

RMC